Navigation Links
Gleevec for Lung Disease

Pulmonary fibrosis is a progressive lung disease that, according to the Pulmonary Fibrosis Foundation, claims the lives of 40,000 people every year. There's often not a known cause although// smoking and some occupations are risk factors. Now, a new treatment may give patients what they're looking for -- more time.

Michael Dixon is enjoying every minute he has with his wife Debbie. Earlier this year, his doctor told him he had a lung disease called pulmonary fibrosis. "He gave me, at most, a 50/50 chance of making five years, and that's when it sunk in," Michael tells Ivanhoe.

He only has half of his lung capacity right now, but as time passes, it will decrease even more. He says, "The hardest part was telling my kids that I might not be around."

Michael is determined to stay around, so he enrolled in a study at Tulane University Health Sciences Center with Pulmonologist Joseph Lasky, M.D..

"The idea of the use of Gleevec is to stop the disease from getting worse once the patient has been diagnosed," Dr. Lasky tells Ivanhoe.

Gleevec has received national attention for its success in treating leukemia. Because fibrosis and cancer share some of the mechanisms of the development of the disease, Dr. Lasky says doctors thought it might be of some benefit for the patients who have fibrosis.

In this disease, scars form on the lungs. Those scars soon take over, and the lungs stop working. Based on lab studies, Dr. Lasky says Gleevec should stop that scarring.

"At best, we hope to stop the progression of the disease," he says. "It's our hope that the treatment of Gleevec will increase the length of their life as well as improve the quality."

The research is currently ongoing to find out just how effective Gleevec is.

For the study, Michael takes six pills a day and hopes they'll give him and his lungs a little more time. "I'd say 99 percent of the time, I believe it's going to work out. I'm hopeful," he says.

There are several sites involved in the study across the United States and one site in Mexico. Most common side effects of Gleevec include nausea and fluid retention.


Related medicine news :

1. Gleevec gets hopeful results
2. "Miracle" Cancer Drug Gleevec Can be Toxic to the Heart
3. Novartis Gleevec Found Effective in Treating Gastro-intestinal Tumors
4. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
5. Vitamins-The answer to Heart Disease?
6. Link between Constipation and Parkinsons Disease
7. Levels Of Blood Proteins May Help Heart Disease Care
8. New Drug PP188 Helps Sickle Cell Disease
9. Gene Treatment for Heart Disease
10. Legume Consumption Can Cut Heart Disease Risk
11. Link Between Infection And Heart Disease
Post Your Comments:

(Date:12/1/2015)... FL (PRWEB) , ... December 01, 2015 , ... ... announces the Multi Jar, a container patent that allows for easier packing and organizing ... the US is worth $90 billion," says Scott Cooper, CEO and Creative Director of ...
(Date:12/1/2015)... ... ... Royal River Natural Foods — a locally-owned, independent natural health store in ... nutritional supplement creatine, along with resistance training for a year, had more new bone ... report is part of the December 2015 issue of Natural Insights for Well Being®, ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an article published ... discrimination claim against the U.S. Department of Health and Human Services, claiming that any ... plans are breaking the clause in the law prohibiting the denial of coverage for ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , one of ... iconic bottle has won top honors in Beverage World Magazine’s Global Packaging Design Awards, ... that it has been selected as a 2015 U.S.A. Taste Champion in the American ...
(Date:12/1/2015)... ... ... Growth in medical payments per workers’ compensation claim in Louisiana slowed from ... care, according to a recent study by the Workers Compensation Research Institute (WCRI). ... payments per claim with more than seven days of lost time continued to be ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015 ... "Medium Molecular Weight Polyisobutylene Market for ... Applications - Global Industry Analysis, Size, Share, ... report to their offering. --> ... of the "Medium Molecular Weight Polyisobutylene ...
(Date:12/1/2015)... /PRNewswire/ -- Royal Philips  (NYSE: PHG, ... imaging software that produces high-contrast images for all anatomies ... grid, at the 2015 Radiological Society of North ... Philips, first digital imaging solution providing grid-like contrast improvement ... workflow and supports "first-time-right imaging" by decreasing the need ...
(Date:12/1/2015)... 2015  Athletic apparel company Tommie Copper ... pay $1.35 million to settle Federal Trade Commission ... compression clothing would relieve severe and chronic pain ... Tommie Copper,s proposed settlement ... its founder and chairman Thomas Kallish ...
Breaking Medicine Technology: